NOTCH3 and ovarian carcinoma: Those expressing high Notch3 levels had decreased overall survival (22 vs. 37 months) and decreased progression-free survival (3 vs. 8 months) suggesting that Notch3 expression is a factor in the recurrence of ovarian cancer as well as a prognostic indicator in recurrent disease [120].